Umar Z Ikram1, Anton E Kunst2, Majda Lamkaddem2, Karien Stronks2. 1. Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands u.ikram@amc.uva.nl. 2. Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Current disease burden estimates do not provide evidence across different ethnic groups. This study aims to assess the disease burden as measured by the disability-adjusted life years (DALYs) for six ethnic groups in Amsterdam, the Netherlands, for 2011 and 2030. METHODS: The DALYs were calculated by combining three components: disease-/sex-/age-specific DALYs per person; disease-specific relative risks (RRs) by ethnicity; and sex-/age-specific population sizes by ethnicity in Amsterdam in 2011 and 2030. Disease-specific DALYs were derived from the National Institute of Public Health. The RRs were obtained through a systematic review of studies published in 1997-2008. The population figures were gathered from the Statistics Netherlands and municipality of Amsterdam. RESULTS: The findings suggest that cardiovascular diseases and anxiety and depressive disorders dominate disease burden in all ethnic groups in 2011 and 2030. In most of the non-Western ethnic minorities, diabetes mellitus is the strongest contributor to the disease burden. The total disease burden will increase more strongly in non-Western ethnic minorities than ethnic Dutch. The 2030 disease burden is estimated to be highest among Surinamese and Antilleans. CONCLUSIONS: In ethnic minorities, diabetes plays an important role in the disease burden, and the total disease burden will grow stronger than ethnic Dutch, resulting in a higher total disease burden for some ethnic groups in 2030. We encourage researchers to estimate the disease burden by ethnicity so that health priorities can be set in the fields of policy, health care and research.
BACKGROUND: Current disease burden estimates do not provide evidence across different ethnic groups. This study aims to assess the disease burden as measured by the disability-adjusted life years (DALYs) for six ethnic groups in Amsterdam, the Netherlands, for 2011 and 2030. METHODS: The DALYs were calculated by combining three components: disease-/sex-/age-specific DALYs per person; disease-specific relative risks (RRs) by ethnicity; and sex-/age-specific population sizes by ethnicity in Amsterdam in 2011 and 2030. Disease-specific DALYs were derived from the National Institute of Public Health. The RRs were obtained through a systematic review of studies published in 1997-2008. The population figures were gathered from the Statistics Netherlands and municipality of Amsterdam. RESULTS: The findings suggest that cardiovascular diseases and anxiety and depressive disorders dominate disease burden in all ethnic groups in 2011 and 2030. In most of the non-Western ethnic minorities, diabetes mellitus is the strongest contributor to the disease burden. The total disease burden will increase more strongly in non-Western ethnic minorities than ethnic Dutch. The 2030 disease burden is estimated to be highest among Surinamese and Antilleans. CONCLUSIONS: In ethnic minorities, diabetes plays an important role in the disease burden, and the total disease burden will grow stronger than ethnic Dutch, resulting in a higher total disease burden for some ethnic groups in 2030. We encourage researchers to estimate the disease burden by ethnicity so that health priorities can be set in the fields of policy, health care and research.
Authors: Anne Karen Jenum; Idunn Brekke; Ibrahimu Mdala; Mirthe Muilwijk; Ambady Ramachandran; Marte Kjøllesdal; Eivind Andersen; Kåre R Richardsen; Anne Douglas; Genevieve Cezard; Aziz Sheikh; Carlos A Celis-Morales; Jason M R Gill; Naveed Sattar; Raj S Bhopal; Erik Beune; Karien Stronks; Per Olav Vandvik; Irene G M van Valkengoed Journal: Diabetologia Date: 2019-06-15 Impact factor: 10.122
Authors: Brecht Devleesschauwer; Charline Maertens de Noordhout; G Suzanne A Smit; Luc Duchateau; Pierre Dorny; Claudia Stein; Herman Van Oyen; Niko Speybroeck Journal: BMC Public Health Date: 2014-11-21 Impact factor: 3.295
Authors: Carmen Betsy Franse; Amy van Grieken; Li Qin; Rene J F Melis; Judith A C Rietjens; Hein Raat Journal: BMJ Open Date: 2018-08-08 Impact factor: 2.692
Authors: Wim J G M Verest; Henrike Galenkamp; Bea Spek; Marieke B Snijder; Karien Stronks; Irene G M van Valkengoed Journal: Eur J Public Health Date: 2019-08-01 Impact factor: 3.367
Authors: Raymond Vanholder; Beatriz Domínguez-Gil; Mirela Busic; Helena Cortez-Pinto; Jonathan C Craig; Kitty J Jager; Beatriz Mahillo; Vianda S Stel; Maria O Valentin; Carmine Zoccali; Gabriel C Oniscu Journal: Nat Rev Nephrol Date: 2021-05-05 Impact factor: 28.314
Authors: Eleonore M Veldhuizen; Sako Musterd; Henriëtte Dijkshoorn; Anton E Kunst Journal: Int J Environ Res Public Health Date: 2015-11-12 Impact factor: 3.390